Our findings thus unveil PKP2 as a master regulator of fibroblast activation and propose AAV9‐PKP2 gene therapy as a promising novel therapeutic strategy targeting pathological fibrosis in HF. This evidence concerns the gene PKP2 and hydrops fetalis.